home / stock / krys / krys articles

KRYS Articles, Krystal Biotech Inc. - From 03/12/24

Stock Information
Company Name: Krystal Biotech Inc.
Stock Symbol: KRYS
Market: NASDAQ
Website: krystalbio.com
Menu
KRYS KRYS Quote KRYS Short KRYS News KRYS Articles KRYS Message Board
Get KRYS Alerts

News, Short Squeeze, Breakout and More Instantly...
$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today | Benzinga

Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 40.23% on an annualized basis producing an average annual return...
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday. Shares of NIO Inc. (NYSE: NIO) rose during Tuesday&rsquo...

$1000 Invested In This Stock 5 Years Ago Would Be Worth $7,400 Today | Benzinga

Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 35.55% on an annualized basis producing an average annual return...

Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference | Benzinga

PITTSBURGH, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, tod...
Krystal Biotech Analysts Increase Their Forecasts Following Q4 Results | Benzinga

Krystal Biotech, Inc. (NASDAQ: KRYS) reported better-than-expected financial results for its fourth quarter on Monday. Krystal Biotech posted quar...

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results. ...

Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference | Benzinga

PITTSBURGH, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company, tod...
AI, Biotech, Energy Sectors Expect M&A Revival For 2024 | Benzinga

Markets are primed for a revival in mergers and acquisitions (M&A) in 2024 following the worst performance in almost a decade for deal-making i...

Krystal Biotech to Present at the Stifel 2023 Healthcare Conference | Benzinga

PITTSBURGH, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company focu...

Krystal Biotech to Report Third Quarter 2023 Financial Results on November 6, 2023 | Benzinga

PITTSBURGH, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the "Company") (NASDAQ:KRYS), a commercial-stage biotechnology company focu...
Previous 10 Next 10